Read + Share
Luedde M, Sedighi J, Hippe HJ, Sossalla S, et al. SGLT2 inhibitors are associated with a reduced incidence of atrial fibrillation
in type 2 diabetes mellitus. Diabetes Obes Metab 2025 Jun 3. doi: 10.1111/dom.16494.
PMID: 40458976
|
 |
|
Luedde M, Sedighi J, Hippe HJ, Sossalla S, et al. SGLT2 inhibitors are associated with a reduced incidence of atrial fibrillation
in type 2 diabetes mellitus. Diabetes Obes Metab 2025 Jun 3. doi: 10.1111/dom.16494.
PMID: 40458976
|
|
|
|